Decreased Concentration of Irisin Is Associated with Poor Functional Outcome in Ischemic Stroke

Low serum concentrations of Irisin are associated with increased risk of hip fracture in Chinese older women

(2018) Jun Yan et al.   JOINT BONE SPINE

Decreased level of irisin, a skeletal muscle cell-derived myokine, is associated with post-stroke depression in the ischemic stroke population

(2018) Wen-Jun Tu et al.   Journal of Neuroinflammation

Circulating irisin levels as a predictive biomarker for sarcopenia: A cross-sectional community-based study

(2017) Jae Seung Chang et al.   Geriatrics & Gerontology International

Association of circulating irisin levels with metabolic and metabolite profiles of Korean adolescents

(2017) Han Byul Jang et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

The novel exercise-induced hormone irisin protects against neuronal injury via activation of the Akt and ERK1/2 signaling pathways and contributes to the neuroprotection of physical exercise in cerebral ischemia

(2017) Dong-Jie Li et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Circulating FABP4 (Fatty Acid–Binding Protein 4) Is a Novel Prognostic Biomarker in Patients With Acute Ischemic Stroke

(2017) Wen-Jun Tu et al.   STROKE

Decreased levels of irisin, a skeletal muscle cell-derived myokine, are related to emphysema associated with chronic obstructive pulmonary disease

(2017) Yukari Sugiyama et al.   International Journal of Chronic Obstructive Pulmonary Disease

Serum Irisin Level Can Predict the Severity of Coronary Artery Disease in Patients with Stable Angina

(2017) Tolga Han Efe et al.   Korean Circulation Journal

Irisin ameliorates depressive-like behaviors in rats by regulating energy metabolism

(2016) Sisi Wang et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Irisin improves endothelial function in obese mice through the AMPK-eNOS pathway

(2015) Fang Han et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice

(2015) Junyan Lu et al.   ATHEROSCLEROSIS

FNDC5 overexpression and irisin ameliorate glucose/lipid metabolic derangements and enhance lipolysis in obesity

(2015) Xiao-Qing Xiong et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Irisin improves fatty acid oxidation and glucose utilization in type 2 diabetes by regulating the AMPK signaling pathway

(2015) C Xin et al.   INTERNATIONAL JOURNAL OF OBESITY

Relationship between serum irisin levels and urinary albumin excretion in patients with type 2 diabetes

(2015) Hao-hua Wang et al.   JOURNAL OF DIABETES AND ITS COMPLICATIONS

Irisin improves endothelial function in type 2 diabetes through reducing oxidative/nitrative stresses

(2015) Di Zhu et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Irisin-encoding gene (FNDC5) variant is associated with changes in blood pressure and lipid profile in type 2 diabetic women but not in men

(2015) Letícia A. Brondani et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Association of serum irisin and body composition with chronic kidney disease in obese Chinese adults: a cross-sectional study

(2015) Shuyu Yang et al.   BMC Nephrology

The relationship between circulating irisin levels and endothelial function in lean and obese subjects

(2014) Ningning Hou et al.   CLINICAL ENDOCRINOLOGY

Serum levels of the myokine irisin in relation to metabolic and renal function

(2014) Thomas Ebert et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events

(2014) K N Aronis et al.   INTERNATIONAL JOURNAL OF OBESITY

Exercise-Induced Irisin Secretion Is Independent of Age or Fitness Level and Increased Irisin May Directly Modulate Muscle Metabolism Through AMPK Activation

(2014) Joo Young Huh et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Circulating irisin, omentin-1, and lipoprotein subparticles in adults at higher cardiovascular risk

(2014) Grigorios Panagiotou et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Irisin: A potentially candidate marker for myocardial infarction

(2014) Tuncay Kuloglu et al.   PEPTIDES

Nontraditional Serum Lipid Variables and Recurrent Stroke Risk

(2014) Jong-Ho Park et al.   STROKE

Plasma irisin depletion under energy restriction is associated with improvements in lipid profile in metabolic syndrome patients

(2013) Rocio de la Iglesia et al.   CLINICAL ENDOCRINOLOGY

Serum irisin levels in new-onset type 2 diabetes

(2013) Yeon-Kyung Choi et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Circulating Irisin in Relation to Insulin Resistance and the Metabolic Syndrome

(2013) Kyung Hee Park et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Irisin Is Expressed and Produced by Human Muscle and Adipose Tissue in Association With Obesity and Insulin Resistance

(2013) José María Moreno-Navarrete et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Irisin: A renaissance in metabolism?

(2013) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients

(2013) Ana B. Crujeiras et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Diabetes Mellitus, Admission Glucose, and Outcomes After Stroke Thrombolysis

(2013) Jean-Philippe Desilles et al.   STROKE

A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis

(2012) Pontus Boström et al.   NATURE

Brachial arterial flow mediated dilation in acute ischemic stroke

(2009) D. Santos-García et al.   EUROPEAN JOURNAL OF NEUROLOGY

ABC/2 for rapid clinical estimate of infarct, perfusion, and mismatch volumes

(2009) J. R. Sims et al.   NEUROLOGY